1,168
Views
10
CrossRef citations to date
0
Altmetric
Research Article

4-Nerolidylcatechol: apoptosis by mitochondrial mechanisms with reduction in cyclin D1 at G0/G1 stage of the chronic myelogenous K562 cell line

, , , , , , , & show all
Pages 1899-1908 | Received 28 Nov 2015, Accepted 22 Mar 2017, Published online: 23 Jun 2017

References

  • Abondanza TS, Oliveira CR, Barbosa CMV, Pereira FE, Cunha RL, Caires AC, Comasseto JV, Queiroz ML, Valadares MC, Bincoletto C. 2008. Bcl-2 expression and apoptosis induction in human HL60 leukaemic cells treated with a novel organotellurium (IV) compound RT-04. Food Chem Toxicol. 46:2540–2545.
  • Agami R, Bernards R. 2000. Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage. Cell. 102:55–66.
  • Alexandrou AT, Li JJ. 2014. Cell cycle regulators guide mitochondrial activity in radiation-induced adaptive response. Antioxid Redox Signal. 20:1463–1480.
  • Ávila RI, Alvarenga CBM, Ávila PHM, Moreira RC, Arruda AF, Fernandes TO, Rodrigues BS, Andrade WM, Batista AC, Paula JR, et al. 2016. Eugenia dysenterica DC. (Myrtaceae) exerts chemopreventive effects against hexavalent chromium-induced damage in vitro and in vivo. Pharm Biol. 54:2652–2663.
  • Bagatela BS, Lopes AP, Fonseca FL, Andreo MA, Nanayakkara DN, Bastos JK, Perazzo FF. 2013. Evaluation of antimicrobial and antimalarial activities of crude extract, fractions and 4-nerolidylcathecol from the aerial parts of Piper umbellata L. (Piperaceae). Nat Prod Res. 27:2202–2209.
  • Barros LFM, Barros PSM, Röpke CD, Silva VV, Sawada TC, Barros SB, Belfort R., Jr. 2007. Dose-dependent in vitro inhibition of rabbit corneal matrix metalloproteinases by an extract of Pothomorphe umbellata after alkali injury. Braz J Med Biol Res. 40:1129–1132.
  • Billen LP, Shamas-Din A, Andrews DW. 2008. Bid: A Bax-like BH3 protein. Oncogene. 27:S93–S104.
  • Bonora M, Pinton P. 2014. The mitochondrial permeability transition pore and cancer: Molecular mechanisms involved in cell death. Front Oncol. 4:1–12.
  • Brohem CA, Sawada TCH, Massaro RR, Almeida RL, Rivelli DP, Ropke CD, da Silva VV, de Lima TM, Curi R, Barros SB, et al. 2009. Apoptosis induction by 4-nerolidylcatechol in melanoma cell lines. Toxicol in Vitro. 23:111–119.
  • Brohem CA, Massaro RR, Tiago M, Marinho CE, Jasiulionis MG, de Almeida RL, Rivelli DP, Albuquerque RC, de Oliveira TF, de Melo Loureiro AP, et al. 2012. Proteasome inhibition and ROS generation by 4-nerolidylcatechol induces melanoma cell death. Pigment Cell Melanoma Res. 25:354–369.
  • Casimiro MC, Velasco-Velázquez M, Aguirre-Alvarado C, Pestell RG. 2014. Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: Past and present. Expert Opin Investig Drugs. 23:295–304.
  • Chen M, Wang J. 2002. Initiator caspases in apoptosis signaling pathways. Apoptosis. 7:313–319.
  • Cortez AP, de Ávila RI, da Cunha CR, Santos AP, Menegatti R, Rezende KR, Valadares MC. 2015. 4-Nerolidylcatechol analogues as promising anticancer agents. Eur J Pharmacol. 765:517–524.
  • Cunha CRM, Mendanha Neto SA, Silva CC, Cortez AP, Gomed MN, Martins FI, Alonso A, Rezende KR, Menegatti R, de Magalhães MT, et al. 2013. 4-Nerolidylcatechol and its synthetic analogues: Antioxidant activity and toxicity evaluation. Eur J Med Chem. 62:371–378.
  • Desmarchelier C, Barros S, Repetto M, Latorre LR, Kato M, Coussio J, Ciccia G. 1997. 4-Nerolidylcatechol from Pothomorphe spp. scavenges peroxyl radicals and inhibits Fe(II)-dependent DNA damage. Planta Med. 63:561–563.
  • Dickson MA, Schwartz GK. 2009. Development of cell-cycle inhibitors for cancer therapy. Curr Oncol. 16:36–43.
  • Elmore S. 2007. Apoptosis: a review of programmed cell death. Toxicol Pathol. 35:495–516.
  • Fernandes TO, Ávila RI, Moura SS, Ribeiro GA, Naves MMV, Valadares MC. 2015. Campomanesia adamantium (Myrtaceae) fruits protect HepG2 cells against carbon tetrachloride-induced toxicity. Toxicol Rep. 2:184–193.
  • Gaeti MPN, Benfica PL, Mendes LP, Vieira MS, Anjos JL, Alonso A, Rezende KR, Valadares MC, Lima EM. 2015. Liposomal entrapment of 4-nerolidylcatechol: Impact on phospholipid dynamics, drug stability and bioactivity. J Nanosci Nanotechnol. 15:838–847.
  • Galluzzi L, Bravo-San Pedro JM, Vitale I, Aaronson SA, Abrams JM, Adam D, Alnemri ES, Altucci L, Andrews D, Annicchiarico-Petruzzelli M, et al. 2015. Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. Cell Death Differ. 22:58–73.
  • Groot RP, Raaijmakers JA, Lammers JW, Koenderman L. 2000. STAT5-dependent cyclinD1 and Bcl-xL expression in Bcr-Abl-transformed cells. Mol Cell Biol Res Commun. 3:299–305.
  • Gustafson KR, Cardellinall JH, McMahon JB, Pannell LK, Cragg GM, Boyd MR. 1992. HIV inhibitory natural products. 6. The peltatols, novel HIV-inhibitory catechol derivatives from Pothomorphe peltata. J Org Chem. 57:2809–2811.
  • Henry CM, Hollville E, Martin SJ. 2013. Measuring apoptosis by microscopy and flow cytometry. Methods. 61:90–97.
  • Huang H-L, Chen Y-C, Huang Y-C, Yang KC, Pan H, Shih SP, Chen YJ. 2011. Lapatinib induces autophagy, apoptosis and megakaryocytic differentiation in chronic myelogenous leukemia K562 cells. PLoS One. 6:e29014.
  • Jiang K, Wang W, Jin X, Wang Z, Ji Z, Meng G. 2015. Silibinin, a natural flavonoid, induces autophagy via ROS-dependent mitochondrial dysfunction and loss of ATP involving BNIP3 in human MCF7 breast cancer cells. Oncol Rep. 33:2711–2718.
  • Koptyra M, Falinski R, Nowicki MO, Stoklosa T, Majsterek I, Nieborowska-Skorska M, Blasiak J, Skorski T. 2006. BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance. Blood. 108:319–327.
  • Krishna IV, Vanaja GR, Kumar NS, Suman G. 2009. Cytotoxic studies of anti-neoplastic drugs on human lymphocytes-in vitro studies. Cancer Biomark. 5:261–272.
  • Lamb R, Harrison H, Hulit J, Smith DL, Lisanti MP, Sotgia F. 2014. Mitochondria as new therapeutic targets for eradicating cancer stem cells: quantitative proteomics and functional validation via MCT1/2 inhibition. Oncotarget. 5:11029–11037.
  • Lamb R, Ozsvari B, Lisanti CL, Tanowitz HB, Howell A, Martinez-Outschoorn Sotgia F, Lisanti MP. 2015. Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: treating cancer like an infectious disease. Oncotarget. 6:4569–4584.
  • Lapenna S, Giordano A. 2009. Cell cycle kinases as therapeutic targets for cancer. Nat Rev Drug Discov. 8:547–566.
  • Madamba SM, Damri KN, Dejean LM, Peixoto PM. 2015. Mitochondrial ion channels in cancer transformation. Front Oncol. 5:1–8.
  • Miller GD, Bruno BJ, Lim CS. 2014. Resistant mutations in CML and Ph(+)ALL-role of ponatinib. Biologics. 8:243–254.
  • Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods. 65:55–63.
  • Mota MF, Benfica PL, Valadares MC. 2012. Synadenium umbellatum Pax. promotes cell cycle arrest and induces apoptosis in K-562 leukemia cells. Braz J Pharm Sci. 48:497–505.
  • Mota MF, Cortez AP, Benfica PL, Rodrigues BS, Castro TF, Macedo LM, Castro CH, Lião LM, Carvalho FS, Romeiro LAS, et al. 2016. Induction of apoptosis in Ehrlich ascites tumour cells via p53 activation by a novel small-molecule MDM2 inhibitor – LQFM030. J Pharm Pharmacol. 68:1143–1159.
  • Mow BM, Blajeski AL, Chandra J, Kaufmann SH. 2001. Apoptosis and the response to anticancer therapy. Curr Opin Oncol. 13:453–462.
  • Park JH, Jin C-Y, Lee BK, Kim GY, Choi YH, Jeong YK. 2008. Naringenin induces apoptosis through downregulation of Akt and caspase-3 activation in human leukemia THP-1 cells. Food Chem Toxicol. 46:3684–3690.
  • Pestell RG. 2013. New roles of cyclin D1. Am J Pathol. 183:3–9.
  • Preston RJ, San Sebastian JR, McFee AF. 1987. The in vitro human lymphocyte assay for assessing the clastogenicity of chemical agents. Mutat Res. 189:175–183.
  • Rasola A, Bernardi P. 2015. Reprint of 'The mitochondrial permeability transition pore and its adaptive responses in tumor cells'. Cell Calcium. 58:18–26.
  • Rezende KR, Barros SBDM. 2004. Quantification of 4-nerolidylcatechol from Pothomorphe umbellata (Piperaceae) in rat plasma samples by HPLC-UV. Rev Bras Cienc Farm. 40:373–380.
  • Robak T, Jamroziak K, Robak P. 2009. Current and emerging treatments for chronic lymphocytic leukaemia. Drugs. 69:2415–2449.
  • Ropke CD, Meirelles RR, da Silva VV, Sawada TC, Barros SB. 2003. Pothomorphe umbellata extract prevents alpha-tocopherol depletion after UV-irradiation. Photochem Photobiol. 78:436–439.
  • Ropke CD, Sawada TCH, da Silva VV, Michalany NS, de Moraes Barros SB. 2005. Photoprotective effect of Pothomorphe umbellata root extract against ultraviolet radiation induced chronic skin damage in the hairless mouse. Clin Exp Dermatol. 30:272–276.
  • Ropke CD, Silva VV, Kera CZ, Miranda DV, de Almeida RL, Sawada TC, Barros SB. 2006. In vitro and in vivo inhibition of skin matrix metalloproteinases by Pothomorphe umbellata root extract. Photochem Photobiol. 82:439–442.
  • Savitskaya MA, Onishchenko MA. 2015. Mechanisms of apoptosis. Biochemistry. 80:1693–1405.
  • Sen S, Takahashi R, Rani S, Freireich EJ, Stass AS. 1993. Expression of differentially phosphorylated Rb and mutant p53 proteins in myeloid leukemia cell lines. Leuk Res. 17:639–647.
  • Silva Pinto AC, Silva LFR, Cavalcanti BC, Melo MR, Chaves FC, Lotufo LV, de Moraes MO, de Andrade-Neto VF, Tadei WP, Pessoa CO, et al. 2009. New antimalarial and cytotoxic 4-nerolidylcatechol derivatives. Eur J Med Chem. 44:2731–2735.
  • Smolej L. 2009. Modern concepts in the treatment of chronic lymphocytic leukemia. Hematology. 14:249–254.
  • Stennicke HR, Salvesen GS. 1998. Properties of the caspases. Biochim Biophys Acta. 1387:17–31.
  • Tait SW, Green DR. 2010. Mitochondria and cell death: Outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol. 11:621–632.
  • Tashiro E, Tsuchiya A, Imoto M. 2007. Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression. Cancer Sci. 98:629–635.
  • Tokarz P, Blasiak J. 2014. Role of mitochondria in carcinogenesis. Acta Biochim Pol. 61:671–678.
  • Valadares MC, Rezende KR, Pereira ER, Sousa MC, Gonçalves B, de Assis JC, Kato MJ. 2007. Protective effects of 4-nerolidylcatechol against genotoxicity induced by cyclophosphamide. Food Chem Toxicol. 45:1975–1978.
  • Vermeulen K, Van Bockstaele DR, Berneman ZN. 2003. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif. 36:131–149.
  • Vousden KH, Prives C. 2009. Blinded by the light: the growing complexity of p53. Cell. 137:413–431.
  • Wang L, Liu L, Shi Y, Cao H, Chaturvedi R, Calcutt MW, Hu T, Ren X, Wilson KT, Polk DB, et al. 2012. Berberine induces caspase-independent cell death in colon tumor cells through activation of apoptosis-inducing factor. PLoS One. 7:e36418.
  • Winter E, Chiaradia LD, Silva AH, Nunes RJ, Yunes RA, Creczynski-Pasa TB. 2014. Involvement of extrinsic and intrinsic apoptotic pathways together with endoplasmic reticulum stress in cell death induced by naphthylchalcones in a leukemic cell line: advantages of multi-target action. Toxicol in Vitro. 28:769–777.
  • Zhang L, Cheng X, Gao Y, Bao J, Guan H, Lu R, Yu H, Xu Q, Sun Y. 2016. Induction of ROS-independent DNA damage by curcumin leads to G2/M cell cycle arrest and apoptosis in human papillary thyroid carcinoma BCPAP cells. Food Funct. 7:315–325.